CKPT — Checkpoint Therapeutics Share News
0.000.00%
Last trade - 00:00- $370.71m
- $337.66m
- $0.04m
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM
Brief: Checkpoint Therapeutics Announces Initiation Of Conterno Phase 3 Trial Of Cosibelimab Combined With Chemotherapy In Patients With First-Line Non-Squamous Non-Small Cell Lung Cancer
Checkpoint Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Checkpoint Therapeutics Reports Q3 Loss Per Share Of $0.14
Checkpoint Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Checkpoint Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Checkpoint Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Checkpoint Therapeutics Q2 Loss Per Share $0.12
Checkpoint Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Twitter, Biogen, Geo Group, Campbell Soup
U.S. STOCKS ON THE MOVE-Campbell Soup, Lordstown Motors, Aethlon Medical, United Natural Foods
Checkpoint Therapeutics: B. Riley starts with 'buy' on lead drug potential
Checkpoint Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Checkpoint Therapeutics Reports First Quarter 2021 Financial Results And Recent Corporate Highlights
Brief: Checkpoint Therapeutics Announces Formation Of Scientific Advisory Board
Chinese spyware code was copied from America's NSA -researchers
Brief: Checkpoint Therapeutics Inc - May Offer, Sell Shares Of Common Stock Having Aggregate Offering Price Of Up To $100 Mln From Time To Time
Brief: Checkpoint Therapeutics Inc Files Mixed Shelf For Up To $100 Million - SEC Filing
Brief: Checkpoint Therapeutics Reports Third Quarter 2020 Financial Results And Recent Corporate Highlights